NCT06686602View on ClinicalTrials.gov

A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer

CompletedOBSERVATIONAL
Enrollment

13,759

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

December 16, 2024

Study Completion Date

March 18, 2025

Conditions
Advanced/Metastatic NSCLCAdvanced/Metastatic HER2-negative Breast Cancer
Interventions
OTHER

No drug

This is a non-interventional study and no study drug will be administered.

Trial Locations (1)

02138

ConcertAI Database, Cambridge

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT06686602 - A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer | Biotech Hunter | Biotech Hunter